Evidence builds for effects of obesity, low physical activity on development of psoriatic arthritisDecember 12, 2019Psoriatic Arthritis
Repeat LTBI testing best in patients taking biologics with new risk factorsDecember 9, 2019Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitisLupus & Connective Tissue Diseases
FDA approves infliximab-axxq for numerous indicationsDecember 6, 2019Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Certolizumab safety profile varies widely across indicationsNovember 27, 2019Psoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
More studies like VERVE needed to test live vaccines in special populationsNovember 25, 2019Rheumatoid ArthritisAnkylosing spondylitisSpondyloarthropathiesPsoriatic Arthritis
SPIRIT-H2H results confirm superiority of ixekizumab over adalimumab for PsANovember 21, 2019Psoriatic Arthritis
FDA announces approval of fifth adalimumab biosimilar, AbriladaNovember 18, 2019Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic ArthritisPain
Expert shares tips for TNF-alpha inhibitor use in special populationsNovember 12, 2019Psoriatic Arthritis
Guselkumab improves psoriatic arthritis regardless of prior TNFi useNovember 11, 2019Psoriatic Arthritis
Patients taking TNF inhibitors can safely receive Zostavax November 11, 2019Rheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitis
AAD-NPF Pediatric psoriasis guideline advises on physical and mental careNovember 9, 2019PediatricsPsoriatic Arthritis
